Lifeboat Foundation

The probe also achieved stable neural recordings in rat brains for up to two years, showing excellent biocompatibility and long-term recording stability, state news agency Xinhua reported.

Cheng Heping, with the Chinese Academy of Sciences and director of the National Centre for Biomedical Imaging Science at Peking University, told Xinhua that the achievement provided a powerful tool for high-throughput simultaneous monitoring of activity in multiple brain regions, and for exploring the relationships between neural activity and behaviour.

This study uncoversthe pivotal role of the enzyme METTL4 in promoting tumor metastasis through the mediation of nuclear N6-methyldeoxyadenosine (6mA) in mammalian cells. By utilizing cellular models, the study demonstrates how hypoxia induces METTL4 to mediate 6mA modifications. This process, in turn, activates genes essential for tumor metastasis, including the involvement of specific long noncoding RNA and a novel HIF-1α co-activator, ZMIZ1. These findings not only shed light on the epigenetic mechanisms driving tumor progression but also establish METTL4 as a prognostic marker for cancer and a potential target for therapeutic intervention. The promise of this discovery lies in its potential to inspire new strategies for combating hypoxia-induced tumor progression, opening avenues for further research and development in cancer treatment.

DNA N6-methyldeoxyadenosine (6mA) has been recognized in various organisms for its role in gene regulation. However, its function in mammalian cells, particularly in the context of cancer, has remained elusive. Previous studies have shown that 6mA modifications can influence gene expression and are present in several species, indicating a potential regulatory role in tumorigenesis. This research addresses a critical gap in understanding the nuclear role of 6mA and its enzymatic mediator METTL4, in mammalian tumor cells, particularly under hypoxia (a common condition in tumor microenvironments that promotes metastasis). The study posits that METTL4-mediated 6mA deposition is a key epigenetic modification that activates metastasis-inducing genes. This finding offers a new perspective on the mechanisms of tumor progression and identifying novel targets for therapeutic intervention.

Continue reading “The Enzyme Leading the Charge Against Tumor metastasis” »

Is it possible that a cure for cancer will be available in one year’s time? A team of Israeli scientists believes so.

But deep learning has a massive drawback: The algorithms can’t justify their answers. Often called the “black box” problem, this opacity stymies their use in high-risk situations, such as in medicine. Patients want an explanation when diagnosed with a life-changing disease. For now, deep learning-based algorithms—even if they have high diagnostic accuracy—can’t provide that information.

To open the black box, a team from the University of Texas Southwestern Medical Center tapped the human mind for inspiration. In a study in Nature Computational Science, they combined principles from the study of brain networks with a more traditional AI approach that relies on explainable building blocks.

The resulting AI acts a bit like a child. It condenses different types of information into “hubs.” Each hub is then transcribed into coding guidelines for humans to read—CliffsNotes for programmers that explain the algorithm’s conclusions about patterns it found in the data in plain English. It can also generate fully executable programming code to try out.

Scientists at Duke-NUS Medical School have identified how the first domino falls after a person encounters an allergen, such as peanuts, shellfish, pollen or dustmites. Their discovery, published in the April issue of Nature Immunology, could herald the development of drugs to prevent these severe reactions.

It is well established that when mast cells, a type of immune cell, mistake a harmless substance, such as peanuts or dust mites, as a threat, they release an immediate first wave of bioactive chemicals against the perceived threat. When mast cells, which reside under the skin, around blood vessels and in the linings of the airways and the gastrointestinal tract, simultaneously release their pre-stored load of bioactive chemicals into the blood, instant and systemic shock can result, which can be lethal without quick intervention.

More than 10 per cent of the global population suffers from food allergies, according to the World Health Organisation (WHO). As allergy rates continue to climb, so does the incidence of food-triggered anaphylaxis and asthma worldwide. In Singapore, asthma affects one in five children while food allergies are already the leading cause of anaphylactic shock.

Researchers from The University of Texas at Dallas and Seoul National University have developed an imager chip inspired by Superman’s X-ray vision that could be used in mobile devices to make it possible to detect objects inside packages or behind walls.

Chip-enabled cellphones might be used to find studs, wooden beams or wiring behind walls, cracks in pipes, or outlines of contents in envelopes and packages. The technology also could have medical applications.

The researchers first demonstrated the imaging technology in a 2022 study. Their latest paper, published in the March print edition of IEEE Transactions on Terahertz Science and Technology, shows how researchers solved one of their biggest challenges: making the technology small enough for handheld mobile devices while improving image quality.

Researchers at the Tulane University School of Medicine are working on a cost-effective, CRISPR-Cas12a-based pathogen detection tool.

Researchers from the Icahn School of Medicine at Mount Sinai have shed valuable light on the nuanced functions and intricate regulatory methods of RNA editing, a critical mechanism underlying brain development and disease.

In a study published June 26 in Nature Communications, the team reported finding major differences between postmortem and living prefrontal cortex brain tissues as they relate to one of the most abundant RNA modifications in the brain, known as adenosine-to-inosine (A-to-I) editing.

This discovery will play a significant role in shaping the development of diagnostics and therapies for brain diseases.

A UCLA Health study explored the traits of resilient individuals, discovering significant neural activities in the brain regions for cognition and emotional regulation, and healthy gut microbiome activities.

The research highlighted differences in microbiome metabolites and gene activity, indicating lower inflammation and better gut health in resilient people compared to less resilient individuals. This comprehensive approach may lead to interventions that enhance resilience to stress, possibly preventing various health issues.

Resilience and Health.